Alison Siedor

Alison Siedor

Goodwin

Contact
View Bio
RSS

Latest Posts › aBLA

Share:

Innovent Announces Results of Phase III Trial of Sintilimab and Bevacizumab Combination Therapy In Patients With Advanced Lung...

Innovent Biologics, Inc. announced the results of the Phase III ORIENT-31 study evaluating sintilimab in combination with BYVASDA (bevacizumab biosimilar) for the treatment of non-squamous non-small cell lung cancer. ...more

11/24/2021  /  aBLA , Biologics , Biosimilars , Food and Drug Administration (FDA) , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide